Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
O125509-5mg | 5mg | In stock | $117.90 | |
O125509-10mg | 10mg | In stock | $187.90 | |
O125509-25mg | 25mg | In stock | $423.90 | |
O125509-50mg | 50mg | Available within 1-2 weeks(?) Item is derived from our semi-finished stock and is processed in 1-2 weeks. | $781.90 |
High affinity and selective EP4antagonist
Synonyms | NCGC00378671-02 | Q27088198 | 4-(4-Cyano-2-(2-(4-fluoronaphthalen-1-yl)propanamido)phenyl)butanoic acid | BCP29725 | AKOS024457689 | 4-[4-cyano-2-[2-(4-fluoronaphthalen-1-yl)propanoylamino]phenyl]butanoic Acid | ONO AE3 208 | ONO-AE3-208, >=98% (HPLC) | F |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | High affinity and selective EP4receptor antagonist (Kivalues are 1.3, 30, 790 and 2400 nM for EP4, EP3, FP and TP receptors respectively). Displays no affinity for EP1, EP2, DP or IP receptors (Ki>10μM). Inhibits PGE2-induced IL-8 production in colonic ep |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of EP 3 receptor;Antagonist of EP 4 receptor |
Product Description | ONO-AE3-208(AE 3-208) is an EP4 antagonist; suppresses cell invasion, migration, and metastasis of prostate cancer. Product description: ONO-AE3-208 is a selective and orally active EP4 receptor antagonist with a Ki of 1.3 nM. ONO-AE3-208 shows less potently affects EP3, FP, and TP receptors (Ki of 30 nM, 790 nM, and 2400 nM, respectively). ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488196540 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488196540 |
IUPAC Name | 4-[4-cyano-2-[2-(4-fluoronaphthalen-1-yl)propanoylamino]phenyl]butanoic acid |
INCHI | InChI=1S/C24H21FN2O3/c1-15(18-11-12-21(25)20-7-3-2-6-19(18)20)24(30)27-22-13-16(14-26)9-10-17(22)5-4-8-23(28)29/h2-3,6-7,9-13,15H,4-5,8H2,1H3,(H,27,30)(H,28,29) |
InChi Key | MTDIMKNAJUQTIO-UHFFFAOYSA-N |
Canonical SMILES | CC(C1=CC=C(C2=CC=CC=C21)F)C(=O)NC3=C(C=CC(=C3)C#N)CCCC(=O)O |
Isomeric SMILES | CC(C1=CC=C(C2=CC=CC=C21)F)C(=O)NC3=C(C=CC(=C3)C#N)CCCC(=O)O |
Alternate CAS | 402473-54-5 |
PubChem CID | 10111831 |
MeSH Entry Terms | 4-(4-cyano-2-(2-(4-fluoronaphthalen-1-yl)propionylamino)phenyl)butyric acid;AE3 208;AE3-208;ONO AE3-208;ONO-AE3-208 |
Molecular Weight | 404.43 |
PubChem SID | 488196540 |
---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
D23191270 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191273 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191274 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191277 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191282 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191296 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D23191298 | Certificate of Analysis | Mar 15, 2023 | O125509 |
D2319446 | Certificate of Analysis | Mar 15, 2023 | O125509 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 40.44, Max Conc. mM: 100; Solvent:1eq. NaOH, Max Conc. mg/mL: 4.04, Max Conc. mM: 10 with gentle warming |
---|